[ACL] YoY Annual Result on 30-Jun-2023 [#FY]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Jun-2023
Financial Year
2023
Quarter
30-Jun-2023 [#FY]
Profit Trend
YoY- -79.86%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Annual Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 689,728 692,103 989,298 641,311 487,530 445,890 376,088 10.62%
PBT 36,366 48,310 254,900 86,653 30,891 -9,704 -7,641 -
Tax 12,122 12,268 76,498 26,264 -10,425 820 1,371 43.75%
NP 23,934 35,901 178,244 60,373 41,255 -10,524 -9,012 -
Tax Rate -33.33% -25.39% -30.01% -30.31% 33.75% - - -
Total Cost 665,794 656,202 811,054 580,938 446,275 456,414 385,100 9.54%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 3.47 5.19 18.02 9.41 8.46 -2.36 -2.40 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.12 0.18 0.89 0.40 0.20 -0.05 -0.04 -
EPS Diluted 0.12 0.18 0.88 0.40 0.20 -0.05 -0.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.